Yesterday, medical device company Uroplasty announced that Brett A. Reynolds has been appointed as Senior Vice President and Chief Financial Officer.
Mr. Reynolds' experience spans over 20 years in finance and operations. He spent 10 years with Synovis Life Technologies, a Twin Cities-based medical device manufacturer acquired by Baxter International last year. While with Synovis, he held various senior positions, including CFO.
Prior to Synovis, Mr. Reynolds served in executive financial positions at Chiquita Processed Foods, Arthur Andersen, and Deloitte & Touche. Mr. Reynolds is a Certified Public Accountant and holds a BA in Accounting and an MBA from the University of Minnesota's Carlson School of Management.
Rob Kill, Uroplasty's President and CEO, remarked, "Brett's significant industry operational experience and proven public company financial leadership will be a valuable asset to Uroplasty. His track record of building strong financial organizations and processes expands the depth of our executive leadership team and we are delighted to have him on board in this key role."
For more information, visit uroplasty.com
Please see disclaimer on the MissionIR website